Teva, Which Recently Became a PhRMA Member, Among 6 Drug Firms Being Sued by 20 States! | Pharmaguy's Insights Into Drug Industry News |

After a series of scandals involving pharmaceutical companies driving up the prices of drugs because ... well, because they can ... Pennsylvania has joined 19 other states in a civil lawsuit charging six generic drug producers with price-fixing.


Led by Connecticut, the states’ claims focus on price increases for broadly prescribed drugs that have increased the costs of state-funded health care programs. The drugs include the delayed-release version of the antibiotic doxycycline hyclate, and the diabetes drug glyburide.


The defendants are Mylan NV, Teva Pharmaceuticals, Mayne Pharma, Heritage Pharmaceuticals Inc., Aurobindo Pharma and Citron Pharma LLC.


According to the suit, company executives conspired to prop up the drug prices by fixing the wholesale prices or agreeing not to compete against one another in certain markets.


Further Reading: